Go to the Table of Contents

Search tables for keyword
Please note: A selected table may take a few minutes to load.

220720
Table 7.1A – Settings Where Mental Health Services Were Received in Past Year: Among People Aged 12 to 17; by Age Group, Numbers in Thousands, 2021
Setting Where Mental Health Service Was Received Total
(2021)		 Aged 12-13
(2021)		 Aged 14-15
(2021)		 Aged 16-17
(2021)
SPECIALTY MENTAL HEALTH SERVICE 4,684 1,433 1,544 1,707
Outpatient 4,459 1,371 1,482 1,606
Private Therapist, Psychologist,
   Psychiatrist, Social Worker, or Counselor		 4,021 1,196 1,347 1,478
Mental Health Clinic or Center 1,362 385 472 505
Partial Day Hospital or Day Treatment Program 426 107 177 143
In-Home Therapist, Counselor, or Family Preservation Worker 1,130 385 397 348
Inpatient or Residential 629 191 176 262
Hospital 577 165 162 250
Residential Treatment Center 249 70 67 112
NONSPECIALTY MENTAL HEALTH SERVICE 3,711 1,303 1,207 1,201
Education1 3,033 1,167 991 875
School Social Worker, School Psychologist, or School Counselor 2,298 890 749 659
Special School or Program within a Regular School for Students
   with Emotional or Behavioral Problems		 1,071 393 362 316
General Medicine        
Pediatrician or Other Family Doctor 977 240 346 391
Juvenile Justice        
Juvenile Detention Center, Prison, or Jail 30 1 19 10
Child Welfare        
Foster Care or Therapeutic Foster Care 96 19 19 58
SPECIALTY MENTAL HEALTH SERVICES AND
NONSPECIALTY MENTAL HEALTH SERVICES		 2,024 692 664 668
VIRTUAL MENTAL HEALTH SERVICE 2,729 742 946 1,040
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Mental health services for people aged 12 to 17 includes treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown mental health services information were excluded.
NOTE: Respondents could indicate multiple service settings; thus, the response categories are not mutually exclusive.
1 Respondents who did not report their school enrollment status, who reported not being enrolled in school in the past 12 months, or who reported being home-schooled were not asked about receipt of mental health services from this setting; however, respondents who reported not being enrolled in school in the past 12 months were classified as not having received mental health services from this setting.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.
220720
Table 7.1B – Settings Where Mental Health Services Were Received in Past Year: Among People Aged 12 to 17; by Age Group, Percentages, 2021
Setting Where Mental Health Service Was Received Total
(2021)		 Aged 12-13
(2021)		 Aged 14-15
(2021)		 Aged 16-17
(2021)
SPECIALTY MENTAL HEALTH SERVICE 18.3 16.3 18.6 20.1
Outpatient 17.5 15.6 17.9 18.9
Private Therapist, Psychologist,
   Psychiatrist, Social Worker, or Counselor		 15.7 13.6 16.2 17.4
Mental Health Clinic or Center 5.3 4.4 5.7 5.9
Partial Day Hospital or Day Treatment Program 1.7 1.2 2.1 1.7
In-Home Therapist, Counselor, or Family Preservation Worker 4.4 4.4 4.8 4.1
Inpatient or Residential 2.5 2.2 2.1 3.1
Hospital 2.2 1.9 1.9 2.9
Residential Treatment Center 1.0 0.8 0.8 1.3
NONSPECIALTY MENTAL HEALTH SERVICE 14.7 15.1 14.6 14.2
Education1 11.9 13.4 12.0 10.4
School Social Worker, School Psychologist, or School Counselor 9.0 10.2 9.0 7.8
Special School or Program within a Regular School for Students
   with Emotional or Behavioral Problems		 4.2 4.5 4.4 3.7
General Medicine        
Pediatrician or Other Family Doctor 3.8 2.7 4.2 4.6
Juvenile Justice        
Juvenile Detention Center, Prison, or Jail 0.1 0.0 0.2 0.1
Child Welfare        
Foster Care or Therapeutic Foster Care 0.4 0.2 0.2 0.7
SPECIALTY MENTAL HEALTH SERVICES AND
NONSPECIALTY MENTAL HEALTH SERVICES		 7.9 7.9 8.0 7.9
VIRTUAL MENTAL HEALTH SERVICE 10.6 8.4 11.4 12.3
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Mental health services for people aged 12 to 17 includes treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown mental health services information were excluded.
NOTE: Respondents could indicate multiple service settings; thus, the response categories are not mutually exclusive.
1 Respondents who did not report their school enrollment status, who reported not being enrolled in school in the past 12 months, or who reported being home-schooled were not asked about receipt of mental health services from this setting; however, respondents who reported not being enrolled in school in the past 12 months were classified as not having received mental health services from this setting.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.
220720
Table 7.2A – Settings Where Mental Health Services Were Received in Past Year: Among People Aged 12 to 17; by Demographic Characteristics, Numbers in Thousands, 2021
Demographic
Characteristic		 SPECIALTY MENTAL HEALTH
SERVICE SETTING1		 NONSPECIALTY MENTAL HEALTH SERVICE SETTING2 VIRTUAL
SERVICES
Total1 Outpatient Inpatient or
Residential		 Total2 Education3 General
Medicine		 Juvenile
Justice		 Child Welfare
2021 2021 2021 2021 2021 2021 2021 2021 2021
TOTAL 4,684 4,459 629 3,711 3,033 977 30 96 2,729
AGE GROUP                  
12-13 1,433 1,371 191 1,303 1,167 240 1 19 742
14-15 1,544 1,482 176 1,207 991 346 19 19 946
16-17 1,707 1,606 262 1,201 875 391 10 58 1,040
GENDER                  
Male 1,709 1,570 303 1,423 1,173 323 22 29 973
Female 2,975 2,888 327 2,288 1,860 654 9 67 1,755
HISPANIC ORIGIN AND RACE                  
Not Hispanic or Latino 3,659 3,468 507 2,799 2,249 802 25 80 2,182
White 2,829 2,719 331 1,993 1,538 656 23 57 1,728
Black or African American 397 335 109 392 354 58 1 17 207
AIAN * * 2 * * * 0 * *
NHOPI * * * * * * * * *
Asian 152 148 17 182 153 41 * 3 85
Two or More Races 205 192 20 151 126 29 * 3 122
Hispanic or Latino 1,025 991 123 913 785 175 6 17 547
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Mental health services for people aged 12 to 17 includes treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown mental health services information were excluded.
NOTE: Respondents could indicate multiple service settings; thus, the response categories are not mutually exclusive.
1 Includes treatment/counseling received as outpatient care (e.g., care from a private therapist, psychologist, psychiatrist, social worker, or counselor; mental health clinic or center; partial day hospital or day treatment program; or in-home therapist, counselor, or family preservation worker) or inpatient or residential care (e.g., an overnight care in a hospital or residential treatment center).
2 Includes treatment/counseling from a school or juvenile justice mental health service provider, a medical doctor, or services received in foster care.
3 Respondents who did not report their school enrollment status, who reported not being enrolled in school in the past 12 months, or who reported being home-schooled were not asked about receipt of mental health services from this setting; however, respondents who reported not being enrolled in school in the past 12 months were classified as not having received mental health services from this setting.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.
220720
Table 7.2B – Settings Where Mental Health Services Were Received in Past Year: Among People Aged 12 to 17; by Demographic Characteristics, Percentages, 2021
Demographic
Characteristic		 SPECIALTY MENTAL HEALTH
SERVICE SETTING1		 NONSPECIALTY MENTAL HEALTH SERVICE SETTING2 VIRTUAL
SERVICES
Total1 Outpatient Inpatient or
Residential		 Total2 Education3 General
Medicine		 Juvenile
Justice		 Child Welfare
2021 2021 2021 2021 2021 2021 2021 2021 2021
TOTAL 18.3 17.5 2.5 14.7 11.9 3.8 0.1 0.4 10.6
AGE GROUP                  
12-13 16.3 15.6 2.2 15.1 13.4 2.7 0.0 0.2 8.4
14-15 18.6 17.9 2.1 14.6 12.0 4.2 0.2 0.2 11.4
16-17 20.1 18.9 3.1 14.2 10.4 4.6 0.1 0.7 12.3
GENDER                  
Male 13.1 12.0 2.3 11.0 9.0 2.5 0.2 0.2 7.4
Female 23.8 23.1 2.6 18.5 15.0 5.2 0.1 0.5 14.0
HISPANIC ORIGIN AND RACE                  
Not Hispanic or Latino 19.2 18.3 2.6 14.9 11.9 4.2 0.1 0.4 11.4
White 21.9 21.0 2.5 15.5 11.9 5.1 0.2 0.4 13.3
Black or African American 11.5 9.7 3.1 11.5 10.3 1.7 0.0 0.5 6.0
AIAN * * 1.4 * * * 0.0 * *
NHOPI * * * * * * * * *
Asian 10.6 10.4 1.2 13.0 10.9 2.9 * 0.2 5.9
Two or More Races 23.1 21.8 2.3 17.3 14.3 3.3 * 0.4 13.7
Hispanic or Latino 15.7 15.1 1.9 14.1 12.1 2.7 0.1 0.3 8.3
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Mental health services for people aged 12 to 17 includes treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown mental health services information were excluded.
NOTE: Respondents could indicate multiple service settings; thus, the response categories are not mutually exclusive.
1 Includes treatment/counseling received as outpatient care (e.g., care from a private therapist, psychologist, psychiatrist, social worker, or counselor; mental health clinic or center; partial day hospital or day treatment program; or in-home therapist, counselor, or family preservation worker) or inpatient or residential care (e.g., an overnight care in a hospital or residential treatment center).
2 Includes treatment/counseling from a school or juvenile justice mental health service provider, a medical doctor, or services received in foster care.
3 Respondents who did not report their school enrollment status, who reported not being enrolled in school in the past 12 months, or who reported being home-schooled were not asked about receipt of mental health services from this setting; however, respondents who reported not being enrolled in school in the past 12 months were classified as not having received mental health services from this setting.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.
220720
Table 7.3A – Settings Where Mental Health Services Were Received in Past Year: Among People Aged 12 to 17; by Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2021
Geographic/Socioeconomic
Characteristic		 SPECIALTY MENTAL HEALTH SERVICE SETTING1 NONSPECIALTY MENTAL HEALTH SERVICE SETTING2 VIRTUAL
SERVICES
Total1 Outpatient Inpatient or
Residential		 Total2 Education3 General
Medicine		 Juvenile
Justice		 Child Welfare
2021 2021 2021 2021 2021 2021 2021 2021 2021
TOTAL 4,684 4,459 629 3,711 3,033 977 30 96 2,729
GEOGRAPHIC REGION                  
Northeast 794 779 54 584 501 138 0 6 506
Midwest 1,092 1,044 144 859 688 276 2 31 605
South 1,648 1,534 271 1,326 1,077 323 26 42 902
West 1,150 1,102 161 942 768 240 2 17 716
COUNTY TYPE                  
Large Metro 2,543 2,458 293 1,957 1,635 480 8 40 1,618
Small Metro 1,481 1,394 232 1,198 976 317 12 30 799
Nonmetro 660 607 103 556 422 180 10 26 312
Urbanized 280 260 32 204 139 79 2 9 138
Less Urbanized 328 300 62 303 240 92 4 17 135
Completely Rural 52 47 9 49 44 9 * * 39
POVERTY LEVEL                  
Less Than 100% 876 781 208 742 605 150 19 43 426
100-199% 976 914 132 838 717 184 5 26 495
200% or More 2,832 2,764 289 2,132 1,712 643 6 27 1,807
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Mental health services for people aged 12 to 17 includes treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown mental health services information were excluded.
NOTE: Respondents could indicate multiple service settings; thus, the response categories are not mutually exclusive.
1 Includes treatment/counseling received as outpatient care (e.g., care from a private therapist, psychologist, psychiatrist, social worker, or counselor; mental health clinic or center; partial day hospital or day treatment program; or in-home therapist, counselor, or family preservation worker) or inpatient or residential care (e.g., an overnight care in a hospital or residential treatment center).
2 Includes treatment/counseling from a school or juvenile justice mental health service provider, a medical doctor, or services received in foster care.
3 Respondents who did not report their school enrollment status, who reported not being enrolled in school in the past 12 months, or who reported being home-schooled were not asked about receipt of mental health services from this setting; however, respondents who reported not being enrolled in school in the past 12 months were classified as not having received mental health services from this setting.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.
220720
Table 7.3B – Settings Where Mental Health Services Were Received in Past Year: Among People Aged 12 to 17; by Geographic and Socioeconomic Characteristics, Percentages, 2021
Geographic/Socioeconomic
Characteristic		 SPECIALTY MENTAL HEALTH SERVICE SETTING1 NONSPECIALTY MENTAL HEALTH SERVICE SETTING2 VIRTUAL
SERVICES
Total1 Outpatient Inpatient or
Residential		 Total2 Education3 General
Medicine		 Juvenile
Justice		 Child Welfare
2021 2021 2021 2021 2021 2021 2021 2021 2021
TOTAL 18.3 17.5 2.5 14.7 11.9 3.8 0.1 0.4 10.6
GEOGRAPHIC REGION                  
Northeast 19.7 19.3 1.3 14.5 12.4 3.4 0.0 0.2 12.5
Midwest 20.3 19.4 2.7 16.1 12.8 5.1 0.0 0.6 11.2
South 16.6 15.4 2.7 13.5 10.9 3.2 0.3 0.4 9.0
West 18.6 17.8 2.6 15.5 12.6 3.9 0.0 0.3 11.6
COUNTY TYPE                  
Large Metro 18.1 17.4 2.1 14.0 11.7 3.4 0.1 0.3 11.4
Small Metro 19.0 17.9 3.0 15.5 12.6 4.1 0.2 0.4 10.2
Nonmetro 18.0 16.6 2.8 15.4 11.6 4.9 0.3 0.7 8.5
Urbanized 19.9 18.5 2.3 14.7 10.0 5.6 0.1 0.7 9.8
Less Urbanized 17.4 15.9 3.3 16.1 12.7 4.8 0.2 0.9 7.1
Completely Rural 14.0 12.7 2.3 13.9 12.2 2.5 * * 10.5
POVERTY LEVEL                  
Less Than 100% 16.8 15.0 4.0 14.4 11.7 2.9 0.4 0.8 8.1
100-199% 17.8 16.7 2.4 15.5 13.2 3.4 0.1 0.5 9.0
200% or More 19.1 18.6 1.9 14.4 11.6 4.3 0.0 0.2 12.1
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Mental health services for people aged 12 to 17 includes treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown mental health services information were excluded.
NOTE: Respondents could indicate multiple service settings; thus, the response categories are not mutually exclusive.
1 Includes treatment/counseling received as outpatient care (e.g., care from a private therapist, psychologist, psychiatrist, social worker, or counselor; mental health clinic or center; partial day hospital or day treatment program; or in-home therapist, counselor, or family preservation worker) or inpatient or residential care (e.g., an overnight care in a hospital or residential treatment center).
2 Includes treatment/counseling from a school or juvenile justice mental health service provider, a medical doctor, or services received in foster care.
3 Respondents who did not report their school enrollment status, who reported not being enrolled in school in the past 12 months, or who reported being home-schooled were not asked about receipt of mental health services from this setting; however, respondents who reported not being enrolled in school in the past 12 months were classified as not having received mental health services from this setting.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.
220720
Table 7.4A – Received Virtual Mental Health Services in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment Status and Demographic Characteristics, Numbers in Thousands, 2021
Demographic Characteristic Aged 12-171
(2021)		 MDE2
(2021)		 MDE with
Severe Impairment2,3
(2021)		 No MDE2
(2021)
TOTAL 2,729 1,318 1,032 1,269
AGE GROUP        
12-13 742 217 180 465
14-15 946 482 383 423
16-17 1,040 619 468 382
GENDER        
Male 973 359 252 581
Female 1,755 959 779 688
HISPANIC ORIGIN AND RACE        
Not Hispanic or Latino 2,182 1,025 803 1,037
White 1,728 794 628 828
Black or African American 207 108 83 95
AIAN * * * *
NHOPI * * * *
Asian 85 * * 33
Two or More Races 122 * * 53
Hispanic or Latino 547 293 229 233
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Virtual mental health services for people aged 12 to 17 includes treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown virtual mental health service information were excluded.
1 The Aged 12-17 column includes respondents with unknown Major Depressive Episode (MDE) and MDE with severe impairment status data.
2 Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
3 Respondents with unknown impairment data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.
220720
Table 7.4B – Received Virtual Mental Health Services in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment Status and Demographic Characteristics, Percentages, 2021
Demographic Characteristic Aged 12-171
(2021)		 MDE2
(2021)		 MDE with
Severe Impairment2,3
(2021)		 No MDE2
(2021)
TOTAL 10.6 26.4 28.2 6.4
AGE GROUP        
12-13 8.4 19.8 23.4 6.3
14-15 11.4 28.7 29.5 6.6
16-17 12.3 27.8 29.4 6.3
GENDER        
Male 7.4 24.4 25.1 5.1
Female 14.0 27.2 29.4 8.1
HISPANIC ORIGIN AND RACE        
Not Hispanic or Latino 11.4 28.6 30.1 6.9
White 13.3 30.5 32.6 8.3
Black or African American 6.0 22.5 22.7 3.2
AIAN * * * *
NHOPI * * * *
Asian 5.9 * * 2.8
Two or More Races 13.7 * * 8.3
Hispanic or Latino 8.3 20.7 23.1 4.7
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Virtual mental health services for people aged 12 to 17 includes treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown virtual mental health service information were excluded.
1 The Aged 12-17 column includes respondents with unknown Major Depressive Episode (MDE) and MDE with severe impairment status data.
2 Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
3 Respondents with unknown impairment data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.
220720
Table 7.5A – Received Virtual Mental Health Services in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment Status and Geographic, Socioeconomic, and Health Characteristics, Numbers in Thousands, 2021
Geographic/Socioeconomic/Health
Characteristic		 Aged 12-171
(2021)		 MDE2
(2021)		 MDE with
Severe Impairment2,3
(2021)		 No MDE2
(2021)
TOTAL 2,729 1,318 1,032 1,269
GEOGRAPHIC REGION        
Northeast 506 248 171 226
Midwest 605 288 218 275
South 902 445 346 424
West 716 338 297 345
COUNTY TYPE        
Large Metro 1,618 811 630 751
Small Metro 799 353 286 393
Nonmetro 312 155 116 126
POVERTY LEVEL        
Less Than 100% 426 210 179 181
100-199% 495 218 165 265
200% or More 1,807 891 688 823
HEALTH INSURANCE4        
Private 1,708 876 675 733
Medicaid/CHIP 951 421 336 478
Other5 156 73 * 78
No Coverage 80 * * 46
OVERALL HEALTH6        
Excellent 539 172 109 348
Very Good 1,040 494 367 497
Good 828 438 374 323
Fair/Poor 322 214 183 101
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Virtual mental health services for people aged 12 to 17 includes treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown virtual mental health service information were excluded.
1 The Aged 12-17 column includes respondents with unknown Major Depressive Episode (MDE) and MDE with severe impairment status data.
2 Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
3 Respondents with unknown impairment data were excluded.
4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
5 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
6 Respondents with unknown health data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.
220720
Table 7.5B – Received Virtual Mental Health Services in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment Status and Geographic, Socioeconomic, and Health Characteristics, Percentages, 2021
Geographic/Socioeconomic/Health
Characteristic		 Aged 12-171
(2021)		 MDE2
(2021)		 MDE with
Severe Impairment2,3
(2021)		 No MDE2
(2021)
TOTAL 10.6 26.4 28.2 6.4
GEOGRAPHIC REGION        
Northeast 12.5 31.9 33.1 7.2
Midwest 11.2 25.1 25.7 6.7
South 9.0 25.6 27.0 5.3
West 11.6 25.3 29.3 7.5
COUNTY TYPE        
Large Metro 11.4 30.6 32.4 6.8
Small Metro 10.2 21.8 23.9 6.5
Nonmetro 8.5 21.1 22.3 4.5
POVERTY LEVEL        
Less Than 100% 8.1 22.6 25.6 4.4
100-199% 9.0 19.6 20.1 6.3
200% or More 12.1 30.1 32.1 7.2
HEALTH INSURANCE4        
Private 12.2 31.6 33.5 6.8
Medicaid/CHIP 9.2 22.1 24.3 5.9
Other5 10.9 25.6 * 7.1
No Coverage 5.9 * * 4.7
OVERALL HEALTH6        
Excellent 6.4 17.9 17.8 4.8
Very Good 10.8 27.7 28.4 6.5
Good 13.3 26.3 29.7 7.5
Fair/Poor 24.2 35.9 36.7 14.7
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Virtual mental health services for people aged 12 to 17 includes treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown virtual mental health service information were excluded.
1 The Aged 12-17 column includes respondents with unknown Major Depressive Episode (MDE) and MDE with severe impairment status data.
2 Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
3 Respondents with unknown impairment data were excluded.
4 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
5 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
6 Respondents with unknown health data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.
220720
Table 7.6A – Reasons for Receiving Most Recent Mental Health Service in Past Year: Among People Aged 12 to 17 Who Received Mental Health Services in the Respective Settings in Past Year; Numbers in Thousands, 2021
Reason for Receipt of Mental Health Service1 SPECIALTY MENTAL HEALTH SERVICE SETTING2 Education3 General Medicine Child Welfare
Total2 Outpatient Inpatient or
Residential
2021 2021 2021 2021 2021 2021
RECEIVED MENTAL HEALTH SERVICES4 4,684 4,459 629 3,033 977 96
Thought about Killing Self or Tried to Kill Self 1,475 1,374 355 406 264 *
Felt Depressed 2,710 2,638 295 986 551 *
Felt Very Afraid and Tense 1,713 1,683 100 716 274 *
Had Eating Problems 816 788 92 187 146 *
Had Other Self-Reported Mental/Neurological Disorder5 151 141 * 28 36 *
Broke Rules and “Acted Out” 658 627 76 290 104 *
Had Trouble Controlling Anger 546 522 35 163 70 *
Got into Physical Fights 56 48 11 50 10 *
Had Problems with Home/Family 1,023 1,002 31 314 78 *
Had Problems with Friends 519 506 16 273 51 *
Had Problems with People Other Than Family/Friends 327 320 10 193 28 *
Had Problems at School 692 667 29 487 77 *
Some Other Reason6 572 560 20 201 65 *
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Mental health services for people aged 12 to 17 includes treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown mental health services information were excluded.
NOTE: Respondents could indicate multiple service settings; thus, the response categories are not mutually exclusive.
1 Respondents could indicate multiple reasons for the last time they received mental health care in a specific service setting; thus, these response categories are not mutually exclusive. Respondents who did not indicate a reason were excluded from the analysis for the particular service category column.
2 Includes treatment/counseling received as outpatient care (e.g., care from a private therapist, psychologist, psychiatrist, social worker, or counselor; mental health clinic or center; partial day hospital or day treatment program; or in-home therapist, counselor, or family preservation worker) or inpatient or residential care (e.g., an overnight care in a hospital or residential treatment center).
3 Respondents who did not report their school enrollment status, who reported not being enrolled in school in the past 12 months, or who reported being home-schooled were not asked about receipt of mental health services or reasons for mental health care from this setting; however, respondents who reported not being enrolled in school in the past 12 months were classified as not having received mental health services from this setting.
4 The Received Mental Health Services row represents all youths who received mental health services regardless of whether a reason is known. The level of unknown data in this row is less than the level of unknown data in the reason for receipt of mental health service rows. The reason for receipt of mental health service rows have a smaller denominator compared to the overall received mental health services row due to the larger amount of unknown reason for treatment data.
5 Respondent self-reported in the write-in question that he or she has a mental or neurological disorder as a reason for having received mental health services. This reason is one of the most commonly reported other reasons for having received mental health services.
6 Respondents with unknown or invalid responses to the write-in question on Some Other Reason for Receiving Mental Health Services were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.
220720
Table 7.6B – Reasons for Receiving Most Recent Mental Health Service in Past Year: Among People Aged 12 to 17 Who Received Mental Health Services in the Respective Settings in Past Year; Percentages, 2021
Reason for Receipt of Mental Health Service1 SPECIALTY MENTAL HEALTH SERVICE SETTING2 Education3 General Medicine Child Welfare
Total2 Outpatient Inpatient or
Residential
2021 2021 2021 2021 2021 2021
RECEIVED MENTAL HEALTH SERVICES4 18.3 17.5 2.5 11.9 3.8 0.4
Thought about Killing Self or Tried to Kill Self 35.0 33.4 73.8 18.8 31.4 *
Felt Depressed 63.6 63.5 61.5 45.6 65.4 *
Felt Very Afraid and Tense 40.7 40.8 20.8 33.1 32.5 *
Had Eating Problems 19.7 19.4 19.3 8.6 17.3 *
Had Other Self-Reported Mental/Neurological Disorder5 3.7 3.5 * 1.3 4.4 *
Broke Rules and “Acted Out” 15.9 15.4 16.0 13.4 12.4 *
Had Trouble Controlling Anger 13.2 12.9 7.5 7.6 8.3 *
Got into Physical Fights 1.4 1.2 2.3 2.3 1.1 *
Had Problems with Home/Family 24.7 24.6 6.5 14.5 9.3 *
Had Problems with Friends 12.5 12.4 3.4 12.6 6.1 *
Had Problems with People Other Than Family/Friends 8.0 7.9 2.2 8.9 3.3 *
Had Problems at School 16.7 16.4 6.2 22.6 9.1 *
Some Other Reason6 14.0 14.0 4.3 9.5 7.8 *
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Mental health services for people aged 12 to 17 includes treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown mental health services information were excluded.
NOTE: Respondents could indicate multiple service settings; thus, the response categories are not mutually exclusive.
1 Respondents could indicate multiple reasons for the last time they received mental health care in a specific service setting; thus, these response categories are not mutually exclusive. Respondents who did not indicate a reason were excluded from the analysis for the particular service category column.
2 Includes treatment/counseling received as outpatient care (e.g., care from a private therapist, psychologist, psychiatrist, social worker, or counselor; mental health clinic or center; partial day hospital or day treatment program; or in-home therapist, counselor, or family preservation worker) or inpatient or residential care (e.g., an overnight care in a hospital or residential treatment center).
3 Respondents who did not report their school enrollment status, who reported not being enrolled in school in the past 12 months, or who reported being home-schooled were not asked about receipt of mental health services or reasons for mental health care from this setting; however, respondents who reported not being enrolled in school in the past 12 months were classified as not having received mental health services from this setting.
4 The Received Mental Health Services row represents all youths who received mental health services regardless of whether a reason is known. The level of unknown data in this row is less than the level of unknown data in the reason for receipt of mental health service rows. The reason for receipt of mental health service rows have a smaller denominator compared to the overall received mental health services row due to the larger amount of unknown reason for treatment data.
5 Respondent self-reported in the write-in question that he or she has a mental or neurological disorder as a reason for having received mental health services. This reason is one of the most commonly reported other reasons for having received mental health services.
6 Respondents with unknown or invalid responses to the write-in question on Some Other Reason for Receiving Mental Health Services were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.
220720
Table 7.7A – Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year: Among People Aged 12 to 17; Receipt of Treatment for Depression in Past Year: Among People Aged 12 to 17 with MDE and among People Aged 12 to 17 with MDE with Severe Impairment in Past Year; by Demographic Characteristics, Numbers in Thousands, 2021
Demographic Characteristic Had MDE
(2021)		 Had MDE with Severe
Impairment1
(2021)		 Received Treatment
for Depression in Past
Year among People
with MDE2
(2021)		 Received Treatment
for Depression in Past
Year among People
with MDE with Severe
Impairment1,2
(2021)
TOTAL 5,017 3,667 2,011 1,604
AGE GROUP        
12-13 1,109 776 366 300
14-15 1,684 1,300 707 583
16-17 2,224 1,590 938 721
GENDER        
Male 1,481 1,006 551 399
Female 3,535 2,661 1,459 1,205
HISPANIC ORIGIN AND RACE        
Not Hispanic or Latino 3,600 2,672 1,591 1,269
White 2,615 1,932 1,234 1,012
Black or African American 479 366 196 145
AIAN * * * *
NHOPI * * * *
Asian 188 136 * *
Two or More Races 239 169 * *
Hispanic or Latino 1,416 994 420 335
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
1 Respondents with unknown impairment data were excluded.
2 Respondents with unknown past year treatment for depression data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.
220720
Table 7.7B – Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year: Among People Aged 12 to 17; Receipt of Treatment for Depression in Past Year: Among People Aged 12 to 17 with MDE and among People Aged 12 to 17 with MDE with Severe Impairment in Past Year; by Demographic Characteristics, Percentages, 2021
Demographic Characteristic Had MDE
(2021)		 Had MDE with Severe
Impairment1
(2021)		 Received Treatment
for Depression in Past
Year among People
with MDE2
(2021)		 Received Treatment
for Depression in Past
Year among People
with MDE with Severe
Impairment1,2
(2021)
TOTAL 20.1 14.7 40.6 44.2
AGE GROUP        
12-13 13.0 9.2 34.0 39.6
14-15 20.7 16.0 42.2 45.1
16-17 26.8 19.2 42.5 45.6
GENDER        
Male 11.5 7.8 37.8 40.3
Female 29.2 22.1 41.7 45.6
HISPANIC ORIGIN AND RACE        
Not Hispanic or Latino 19.4 14.4 44.6 47.8
White 20.7 15.3 47.4 52.5
Black or African American 14.0 10.7 41.2 39.8
AIAN * * * *
NHOPI * * * *
Asian 13.8 10.0 * *
Two or More Races 27.2 19.3 * *
Hispanic or Latino 22.2 15.7 30.2 34.2
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
1 Respondents with unknown impairment data were excluded.
2 Respondents with unknown past year treatment for depression data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.
220720
Table 7.8A – Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year: Among People Aged 12 to 17; Receipt of Treatment for Depression in Past Year: Among People Aged 12 to 17 with MDE and among People Aged 12 to 17 with MDE with Severe Impairment in Past Year; by Geographic, Socioeconomic, and Health Characteristics, Numbers in Thousands, 2021
Geographic/Socioeconomic/
Health Characteristic		 Had MDE
(2021)		 Had MDE
with Severe Impairment1
(2021)		 Received Treatment for
Depression in Past Year
among People with MDE2
(2021)		 Received Treatment for
Depression in Past Year
among People with MDE
with Severe
Impairment1,2
(2021)
TOTAL 5,017 3,667 2,011 1,604
GEOGRAPHIC REGION        
Northeast 776 516 294 209
Midwest 1,160 854 513 401
South 1,742 1,281 722 568
West 1,339 1,017 482 426
COUNTY TYPE        
Large Metro 2,655 1,944 1,076 843
Small Metro 1,622 1,199 640 542
Nonmetro 740 524 295 220
POVERTY LEVEL        
Less Than 100% 933 702 323 281
100-199% 1,112 824 410 356
200% or More 2,972 2,141 1,277 966
HEALTH INSURANCE3        
Private 2,778 2,017 1,236 946
Medicaid/CHIP 1,910 1,391 737 620
Other4 285 220 * *
No Coverage 315 251 * *
OVERALL HEALTH5        
Excellent 959 611 303 237
Very Good 1,791 1,294 777 585
Good 1,670 1,264 647 539
Fair/Poor 597 498 283 242
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
1 Respondents with unknown impairment data were excluded.
2 Respondents with unknown past year treatment for depression data were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
5 Respondents with unknown health data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.
220720
Table 7.8B – Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year: Among People Aged 12 to 17; Receipt of Treatment for Depression in Past Year: Among People Aged 12 to 17 with MDE and among People Aged 12 to 17 with MDE with Severe Impairment in Past Year; by Geographic, Socioeconomic, and Health Characteristics, Percentages, 2021
Geographic/Socioeconomic/
Health Characteristic		 Had MDE
(2021)		 Had MDE
with Severe Impairment1
(2021)		 Received Treatment for
Depression in Past Year
among People with MDE2
(2021)		 Received Treatment for
Depression in Past Year
among People with MDE
with Severe
Impairment1,2
(2021)
TOTAL 20.1 14.7 40.6 44.2
GEOGRAPHIC REGION        
Northeast 19.8 13.2 38.7 41.5
Midwest 22.0 16.2 44.5 47.3
South 17.8 13.1 42.0 44.7
West 22.5 17.2 36.4 42.3
COUNTY TYPE        
Large Metro 19.3 14.2 41.0 43.8
Small Metro 21.2 15.7 39.9 45.7
Nonmetro 20.8 14.8 40.3 42.2
POVERTY LEVEL        
Less Than 100% 18.2 13.7 35.8 41.1
100-199% 20.8 15.5 37.7 44.2
200% or More 20.5 14.8 43.0 45.1
HEALTH INSURANCE3        
Private 20.5 14.9 44.7 47.1
Medicaid/CHIP 19.0 13.9 39.6 45.4
Other4 20.4 15.8 * *
No Coverage 23.9 19.2 * *
OVERALL HEALTH5        
Excellent 11.6 7.4 31.6 38.9
Very Good 19.0 13.8 44.1 45.9
Good 28.0 21.2 39.4 43.2
Fair/Poor 46.4 39.3 47.9 48.8
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
1 Respondents with unknown impairment data were excluded.
2 Respondents with unknown past year treatment for depression data were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
5 Respondents with unknown health data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.
220720
Table 7.9A – Substance Use in Past Year and Past Month: Among People Aged 12 to 17; by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment Status, Numbers in Thousands, 2021
Substance Had MDE
(2021)		 Had MDE with Severe
Impairment1
(2021)		 Had No MDE
(2021)
PAST YEAR USE      
Illicit Drugs 1,389 1,129 2,138
Marijuana 1,020 808 1,599
Cocaine 6 6 24
Crack 1 1 2
Heroin * * *
Hallucinogens 139 115 197
LSD 103 83 136
PCP 4 4 12
Ecstasy 39 36 48
Inhalants 258 225 336
Methamphetamine 14 14 21
Misuse of Prescription Psychotherapeutics 374 331 425
Pain Relievers 209 187 254
Stimulants 140 120 154
Tranquilizers or Sedatives 117 115 96
Tranquilizers 100 97 86
Sedatives 29 29 11
Benzodiazepines 82 79 87
Opioids 209 187 254
Central Nervous System Stimulants 142 122 175
Illicit Drugs Other Than Marijuana2 628 541 868
PAST MONTH USE      
Alcohol 674 502 1,084
Binge Alcohol Use3 338 268 618
Heavy Alcohol Use 33 22 68
Cigarette Use 162 129 209
Daily Cigarette Use 4 4 46
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
1 Respondents with unknown impairment data were excluded.
2 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.
3 Estimates of binge alcohol use include use by those who were heavy alcohol users.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.
220720
Table 7.9B – Substance Use in Past Year and Past Month: Among People Aged 12 to 17; by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment Status, Percentages, 2021
Substance Had MDE
(2021)		 Had MDE with Severe
Impairment1
(2021)		 Had No MDE
(2021)
PAST YEAR USE      
Illicit Drugs 27.7 30.8 10.7
Marijuana 20.3 22.0 8.0
Cocaine 0.1 0.2 0.1
Crack 0.0 0.0 0.0
Heroin * * *
Hallucinogens 2.8 3.1 1.0
LSD 2.0 2.3 0.7
PCP 0.1 0.1 0.1
Ecstasy 0.8 1.0 0.2
Inhalants 5.1 6.1 1.7
Methamphetamine 0.3 0.4 0.1
Misuse of Prescription Psychotherapeutics 7.5 9.0 2.1
Pain Relievers 4.2 5.1 1.3
Stimulants 2.8 3.3 0.8
Tranquilizers or Sedatives 2.3 3.1 0.5
Tranquilizers 2.0 2.6 0.4
Sedatives 0.6 0.8 0.1
Benzodiazepines 1.6 2.1 0.4
Opioids 4.2 5.1 1.3
Central Nervous System Stimulants 2.8 3.3 0.9
Illicit Drugs Other Than Marijuana2 12.5 14.8 4.4
PAST MONTH USE      
Alcohol 13.4 13.7 5.4
Binge Alcohol Use3 6.7 7.3 3.1
Heavy Alcohol Use 0.7 0.6 0.3
Cigarette Use 3.2 3.5 1.0
Daily Cigarette Use 0.1 0.1 0.2
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
1 Respondents with unknown impairment data were excluded.
2 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.
3 Estimates of binge alcohol use include use by those who were heavy alcohol users.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.
220720
Table 7.10A – Major Depressive Episode in Past Year: Among People Aged 12 to 17; by Past Year Substance Use Disorder Status and Demographic Characteristics, Numbers in Thousands, 2021
Substance Use Disorder Status/Age Group Total
(2021)		 Male
(2021)		 Female
(2021)
SUBSTANCE USE DISORDER1 935 285 649
12-13 * * *
14-15 282 * 227
16-17 522 187 335
Drug Use Disorder1 727 239 488
12-13 * * *
14-15 216 * *
16-17 421 * 260
Alcohol Use Disorder 457 * 344
12-13 * * *
14-15 * * *
16-17 263 * *
NO SUBSTANCE USE DISORDER1 4,082 1,196 2,886
12-13 977 198 779
14-15 1,402 454 948
16-17 1,703 544 1,159
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table include prescription drug use disorder data from all past year users of prescription drugs. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details on these changes.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
1 Drug use includes the use of marijuana (including vaping), cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine in the past year or any use (i.e., not necessarily misuse) of prescription pain relievers, tranquilizers, stimulants, or sedatives in the past year.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.
220720
Table 7.10B – Major Depressive Episode in Past Year: Among People Aged 12 to 17; by Past Year Substance Use Disorder Status and Demographic Characteristics, Percentages, 2021
Substance Use Disorder Status/Age Group Total
(2021)		 Male
(2021)		 Female
(2021)
SUBSTANCE USE DISORDER1 44.1 31.5 53.4
12-13 * * *
14-15 43.4 * 57.2
16-17 43.5 35.0 50.3
Drug Use Disorder1 43.4 31.9 52.7
12-13 * * *
14-15 44.1 * *
16-17 43.2 * 49.1
Alcohol Use Disorder 53.1 * 60.7
12-13 * * *
14-15 * * *
16-17 54.5 * *
NO SUBSTANCE USE DISORDER1 17.9 10.0 26.5
12-13 11.9 4.6 19.8
14-15 18.7 11.2 27.5
16-17 23.9 15.0 33.2
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table include prescription drug use disorder data from all past year users of prescription drugs. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details on these changes.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
1 Drug use includes the use of marijuana (including vaping), cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine in the past year or any use (i.e., not necessarily misuse) of prescription pain relievers, tranquilizers, stimulants, or sedatives in the past year.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.
220720
Table 7.11A – Major Depressive Episode with Severe Impairment in Past Year: Among People Aged 12 to 17; by Past Year Substance Use Disorder Status and Demographic Characteristics, Numbers in Thousands, 2021
Substance Use Disorder Status/Age Group Total
(2021)		 Male
(2021)		 Female
(2021)
SUBSTANCE USE DISORDER1 724 188 536
12-13 * * *
14-15 245 * 197
16-17 383 119 264
Drug Use Disorder1 574 159 415
12-13 * * *
14-15 189 * *
16-17 310 99 211
Alcohol Use Disorder 362 * 275
12-13 * * *
14-15 * * *
16-17 199 * *
NO SUBSTANCE USE DISORDER1 2,942 818 2,124
12-13 681 119 562
14-15 1,055 306 748
16-17 1,207 393 814
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table include prescription drug use disorder data from all past year users of prescription drugs. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details on these changes.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
NOTE: Respondents with unknown impairment data were excluded.
1 Drug use includes the use of marijuana (including vaping), cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine in the past year or any use (i.e., not necessarily misuse) of prescription pain relievers, tranquilizers, stimulants, or sedatives in the past year.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.
220720
Table 7.11B – Major Depressive Episode with Severe Impairment in Past Year: Among People Aged 12 to 17; by Past Year Substance Use Disorder Status and Demographic Characteristics, Percentages, 2021
Substance Use Disorder Status/Age Group Total
(2021)		 Male
(2021)		 Female
(2021)
SUBSTANCE USE DISORDER1 34.3 20.8 44.4
12-13 * * *
14-15 37.8 * 49.7
16-17 32.1 22.3 40.0
Drug Use Disorder1 34.3 21.2 44.9
12-13 * * *
14-15 38.6 * *
16-17 31.7 22.2 39.8
Alcohol Use Disorder 42.3 * 49.1
12-13 * * *
14-15 * * *
16-17 41.7 * *
NO SUBSTANCE USE DISORDER1 12.9 6.8 19.6
12-13 8.3 2.8 14.4
14-15 14.1 7.6 21.7
16-17 17.0 10.9 23.4
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table include prescription drug use disorder data from all past year users of prescription drugs. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details on these changes.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
NOTE: Respondents with unknown impairment data were excluded.
1 Drug use includes the use of marijuana (including vaping), cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine in the past year or any use (i.e., not necessarily misuse) of prescription pain relievers, tranquilizers, stimulants, or sedatives in the past year.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.
220720
Table 7.12A – Substance Use Disorder Status in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment Status and Demographic Characteristics, Numbers in Thousands, 2021
MDE Status/Demographic Characteristic SUBSTANCE USE DISORDER STATUS
No Substance Use
Disorder1		 Substance Use Disorder
Drugs1 Marijuana Any Use of Opioids Alcohol Both Drugs
and Alcohol1		 Drugs or Alcohol1
2021 2021 2021 2021 2021 2021 2021
TOTAL2 23,795 1,763 1,256 259 894 433 2,224
MDE 4,082 727 507 120 457 250 935
Age Group              
12-13 977 90 29 43 52 11 132
14-15 1,402 216 145 40 142 76 282
16-17 1,703 421 333 37 263 163 522
Gender              
Male 1,196 239 186 40 114 68 285
Female 2,886 488 321 80 344 182 649
MDE with Severe Impairment 2,942 574 392 106 362 212 724
Age Group              
12-13 681 76 28 29 31 11 96
14-15 1,055 189 124 40 132 76 245
16-17 1,207 310 240 36 199 125 383
Gender              
Male 818 159 133 29 87 58 188
Female 2,124 415 259 78 275 154 536
NO MDE 18,757 949 693 127 405 167 1,187
Age Group              
12-13 7,264 121 41 33 53 31 142
14-15 6,087 274 191 30 132 39 367
16-17 5,407 555 461 64 220 96 678
Gender              
Male 10,765 512 382 46 182 73 621
Female 7,992 438 310 81 223 94 566
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table include prescription drug use disorder data from all past year users of prescription drugs. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details on these changes.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
NOTE: Respondents with unknown impairment data were excluded.
1 Drug use includes the use of marijuana (including vaping), cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine in the past year or any use (i.e., not necessarily misuse) of prescription pain relievers, tranquilizers, stimulants, or sedatives in the past year.
2 The Total row includes respondents with unknown past year MDE information.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.
220720
Table 7.12B – Substance Use Disorder Status in Past Year: Among People Aged 12 to 17; by Past Year Major Depressive Episode (MDE) and MDE with Severe Impairment Status and Demographic Characteristics, Percentages, 2021
MDE Status/Demographic Characteristic SUBSTANCE USE DISORDER STATUS
No Substance Use
Disorder1		 Substance Use Disorder
Drugs1 Marijuana Any Use of Opioids Alcohol Both Drugs
and Alcohol1		 Drugs or Alcohol1
2021 2021 2021 2021 2021 2021 2021
TOTAL2 91.5 6.8 4.8 1.0 3.4 1.7 8.5
MDE 81.4 14.5 10.1 2.4 9.1 5.0 18.6
Age Group              
12-13 88.1 8.1 2.6 3.9 4.7 1.0 11.9
14-15 83.3 12.8 8.6 2.4 8.4 4.5 16.7
16-17 76.6 18.9 15.0 1.7 11.8 7.3 23.4
Gender              
Male 80.7 16.2 12.6 2.7 7.7 4.6 19.3
Female 81.6 13.8 9.1 2.3 9.7 5.2 18.4
MDE with Severe Impairment 80.3 15.7 10.7 2.9 9.9 5.8 19.7
Age Group              
12-13 87.7 9.7 3.7 3.8 4.0 1.4 12.3
14-15 81.1 14.5 9.5 3.1 10.1 5.8 18.9
16-17 75.9 19.5 15.1 2.3 12.5 7.9 24.1
Gender              
Male 81.3 15.8 13.2 2.8 8.6 5.7 18.7
Female 79.8 15.6 9.7 2.9 10.3 5.8 20.2
NO MDE 94.0 4.8 3.5 0.6 2.0 0.8 6.0
Age Group              
12-13 98.1 1.6 0.6 0.4 0.7 0.4 1.9
14-15 94.3 4.2 3.0 0.5 2.0 0.6 5.7
16-17 88.9 9.1 7.6 1.1 3.6 1.6 11.1
Gender              
Male 94.5 4.5 3.4 0.4 1.6 0.6 5.5
Female 93.4 5.1 3.6 0.9 2.6 1.1 6.6
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table include prescription drug use disorder data from all past year users of prescription drugs. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details on these changes.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
NOTE: Respondents with unknown impairment data were excluded.
1 Drug use includes the use of marijuana (including vaping), cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine in the past year or any use (i.e., not necessarily misuse) of prescription pain relievers, tranquilizers, stimulants, or sedatives in the past year.
2 The Total row includes respondents with unknown past year MDE information.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.
220720
Table 7.13A – Co-Occurring Use Disorder and Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year: Among People Aged 12 to 17; by Gender, Numbers in Thousands, 2021
Use Disorder and MDE Total
(2021)		 Male
(2021)		 Female
(2021)
Substance Use Disorder and MDE1,2 935 285 649
Substance Use Disorder and MDE with Severe Impairment1,2 724 188 536
Illicit Drug or Alcohol Use Disorder and MDE3 842 259 583
Illicit Drug or Alcohol Use Disorder and MDE with Severe
   Impairment3		 651 173 478
Drug Use Disorder and MDE1,2 727 239 488
Drug Use Disorder and MDE with Severe Impairment1,2 574 159 415
Alcohol Use Disorder and MDE 457 114 344
Alcohol Use Disorder and MDE with Severe Impairment 362 87 275
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details on these changes.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
NOTE: Respondents with unknown impairment data were excluded.
1 Drug use includes the use of marijuana (including vaping), cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine in the past year or any use (i.e., not necessarily misuse) of prescription pain relievers, tranquilizers, stimulants, or sedatives in the past year.
2 These estimates include prescription drug use disorder data from all past year users of prescription drugs.
3 These estimates do not include prescription drug use disorder data from the past year users of prescription drugs who were not also misusers of prescription drugs.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.
220720
Table 7.13B – Co-Occurring Use Disorder and Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year: Among People Aged 12 to 17; by Gender, Percentages, 2021
Use Disorder and MDE Total
(2021)		 Male
(2021)		 Female
(2021)
Substance Use Disorder and MDE1,2 3.7 2.2 5.4
Substance Use Disorder and MDE with Severe Impairment1,2 2.9 1.5 4.5
Illicit Drug or Alcohol Use Disorder and MDE3 3.4 2.0 4.8
Illicit Drug or Alcohol Use Disorder and MDE with Severe
   Impairment3		 2.6 1.3 4.0
Drug Use Disorder and MDE1,2 2.9 1.9 4.0
Drug Use Disorder and MDE with Severe Impairment1,2 2.3 1.2 3.4
Alcohol Use Disorder and MDE 1.8 0.9 2.8
Alcohol Use Disorder and MDE with Severe Impairment 1.5 0.7 2.3
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details on these changes.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
NOTE: Respondents with unknown impairment data were excluded.
1 Drug use includes the use of marijuana (including vaping), cocaine (including crack), heroin, hallucinogens, inhalants, or methamphetamine in the past year or any use (i.e., not necessarily misuse) of prescription pain relievers, tranquilizers, stimulants, or sedatives in the past year.
2 These estimates include prescription drug use disorder data from all past year users of prescription drugs.
3 These estimates do not include prescription drug use disorder data from the past year users of prescription drugs who were not also misusers of prescription drugs.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.
220720
Table 7.14A – Types of Professionals Seen: Among People Aged 12 to 17 with Major Depressive Episode (MDE) and among People Aged 12 to 17 with MDE with Severe Impairment in Past Year Who Saw or Talked to a Professional about Depression in Past Year; Numbers in Thousands, 2021
Type of Professional1 MDE
(2021)		 MDE with Severe Impairment2
(2021)
TOTAL 1,895 1,533
HEALTH PROFESSIONAL 1,822 1,479
General Practitioner or Family Doctor 522 421
Other Medical Doctor3 110 92
Psychologist 638 504
Psychiatrist or Psychotherapist 581 481
Social Worker 282 245
Counselor 1,048 880
Other Mental Health Professional4 296 242
Nurse, Occupational Therapist, or Other Health Professional 248 225
ALTERNATIVE SERVICE PROFESSIONAL 133 107
Religious or Spiritual Advisor 76 55
Herbalist, Chiropractor, Acupuncturist, or Massage Therapist 58 53
OTHER PROFESSIONAL5 2 2
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
1 Respondents could indicate multiple types of professionals; thus, these response categories are not mutually exclusive. Respondents with unknown type of professional data were excluded from the estimates for each specific type of professional but were included in the Total row.
2 Respondents with unknown impairment data were excluded.
3 Other Medical Doctor includes cardiologists, gynecologists, urologists, and other medical doctors that are not general practitioners or family doctors.
4 Other Mental Health Professional includes mental health nurses and other therapists where type is not specified.
5 Respondents with unknown or invalid responses to the write-in question on other types of professionals seen for depression were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.
220720
Table 7.14B – Types of Professionals Seen: Among People Aged 12 to 17 with Major Depressive Episode (MDE) and among People Aged 12 to 17 with MDE with Severe Impairment in Past Year Who Saw or Talked to a Professional about Depression in Past Year; Percentages, 2021
Type of Professional1 MDE
(2021)		 MDE with Severe Impairment2
(2021)
TOTAL 100.0 100.0
HEALTH PROFESSIONAL 98.9 98.8
General Practitioner or Family Doctor 28.4 28.1
Other Medical Doctor3 6.0 6.2
Psychologist 34.6 33.6
Psychiatrist or Psychotherapist 31.5 32.1
Social Worker 15.3 16.3
Counselor 56.9 58.7
Other Mental Health Professional4 16.1 16.1
Nurse, Occupational Therapist, or Other Health Professional 13.5 15.0
ALTERNATIVE SERVICE PROFESSIONAL 7.2 7.1
Religious or Spiritual Advisor 4.1 3.7
Herbalist, Chiropractor, Acupuncturist, or Massage Therapist 3.2 3.6
OTHER PROFESSIONAL5 0.1 0.1
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
1 Respondents could indicate multiple types of professionals; thus, these response categories are not mutually exclusive. Respondents with unknown type of professional data were excluded from the estimates for each specific type of professional but were included in the Total row.
2 Respondents with unknown impairment data were excluded.
3 Other Medical Doctor includes cardiologists, gynecologists, urologists, and other medical doctors that are not general practitioners or family doctors.
4 Other Mental Health Professional includes mental health nurses and other therapists where type is not specified.
5 Respondents with unknown or invalid responses to the write-in question on other types of professionals seen for depression were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.
220720
Table 7.15A – Type of Treatment Received in Past Year for Depression: Among People Aged 12 to 17 with Major Depressive Episode in Past Year; by Demographic and Socioeconomic Characteristics, Numbers in Thousands, 2021
Demographic/Socioeconomic Characteristic Saw or Talked to a
Health Professional OR
Used Prescription
Medication
(2021)		 Saw or Talked to a
Health Professional BUT
Did Not Use Prescription
Medication
(2021)		 Used Prescription
Medication BUT Did Not
See or Talk
to a Health Professional
(2021)		 Saw or Talked to a
Health Professional AND
Used Prescription
Medication
(2021)
TOTAL 1,959 912 113 909
GENDER        
Male 528 222 47 245
Female 1,430 690 66 664
HISPANIC ORIGIN AND RACE        
Not Hispanic or Latino 1,553 699 84 753
White 1,213 509 56 629
Black or African American 180 114 * 43
AIAN * * * *
NHOPI * * * *
Asian * * * *
Two or More Races * * 4 23
Hispanic or Latino 406 213 29 157
POVERTY LEVEL        
Less Than 100% 318 161 27 125
100-199% 391 205 28 158
200% or More 1,249 547 58 627
HEALTH INSURANCE1        
Private 1,212 562 48 588
Medicaid/CHIP 720 318 73 319
Other2 * * * 49
No Coverage * * 1 *
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Respondents with unknown past year treatment for depression data were excluded.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
1 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
2 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.
220720
Table 7.15B – Type of Treatment Received in Past Year for Depression: Among People Aged 12 to 17 with Major Depressive Episode in Past Year; by Demographic and Socioeconomic Characteristics, Percentages, 2021
Demographic/Socioeconomic Characteristic Saw or Talked to a
Health Professional OR
Used Prescription
Medication
(2021)		 Saw or Talked to a
Health Professional BUT
Did Not Use Prescription
Medication
(2021)		 Used Prescription
Medication BUT Did Not
See or Talk
to a Health Professional
(2021)		 Saw or Talked to a
Health Professional AND
Used Prescription
Medication
(2021)
TOTAL 39.8 18.5 2.3 18.3
GENDER        
Male 36.7 15.4 3.2 16.9
Female 41.0 19.7 1.9 18.9
HISPANIC ORIGIN AND RACE        
Not Hispanic or Latino 43.8 19.7 2.4 21.1
White 46.8 19.6 2.2 24.3
Black or African American 38.9 24.7 * 9.1
AIAN * * * *
NHOPI * * * *
Asian * * * *
Two or More Races * * 1.7 9.5
Hispanic or Latino 29.4 15.5 2.1 11.2
POVERTY LEVEL        
Less Than 100% 35.3 17.8 2.9 13.6
100-199% 36.4 19.0 2.6 14.4
200% or More 42.4 18.5 2.0 21.3
HEALTH INSURANCE1        
Private 44.0 20.4 1.7 21.3
Medicaid/CHIP 38.9 17.1 3.9 16.9
Other2 * * * 17.0
No Coverage * * 0.2 *
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Respondents with unknown past year treatment for depression data were excluded.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
1 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
2 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.
220720
Table 7.16A – Received Substance Use Treatment at a Specialty Facility and/or Mental Health Services (Specialty or Nonspecialty) Including Virtual Services in Past Year: Among People Aged 12 to 17; by Past Year Illicit Drug or Alcohol Use Disorder and Major Depressive Episode (MDE) and MDE with Severe Impairment Status and Age Group, Numbers in Thousands, 2021
Illicit Drug or Alcohol Use Disorder
Status/MDE Status/Age Group		 Received Substance Use
Treatment (SU Tx) at
a Specialty Facility OR
Mental Health (MH)
Services Including
Virtual Services (VS)
(2021)		 Received
SU Tx at a
Specialty
Facility BUT NOT MH
Services Including VS
(2021)		 Received
MH Services Including VS
BUT NOT
SU Tx at a Specialty
Facility
(2021)		 Received
SU Tx at
a Specialty Facility AND
MH Services Including VS
(2021)		 Received NEITHER SU
Tx at a Specialty Facility
NOR MH Services
Including VS
(2021)
Illicit Drug or Alcohol Use Disorder and MDE 471 * 440 31 368
12-13 * * * * *
14-15 * * * 9 *
16-17 240 * 219 * 248
Illicit Drug or Alcohol Use Disorder and
   MDE with Severe Impairment		 370 * 339 31 278
12-13 * * * * *
14-15 * * * 9 *
16-17 * * * * *
Illicit Drug or Alcohol Use Disorder and
   No MDE		 326 7 312 5 688
12-13 * * * * *
14-15 * * * 0 *
16-17 197 4 189 4 416
MDE and No Illicit Drug or Alcohol Use
   Disorder		 2,104 * 2,104 * 2,024
12-13 457 * 457 * 513
14-15 712 * 712 * 720
16-17 935 * 935 0 791
No Illicit Drug or Alcohol Use Disorder and
   No MDE		 3,471 7 3,464 * 15,146
12-13 1,437 1 1,436 * 5,680
14-15 1,132 6 1,126 0 4,934
16-17 903 * 902 * 4,533
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Illicit drug or alcohol use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table do not include prescription drug use disorder data from the past year users of prescription drugs who were not also misusers of prescription drugs. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details on these changes.
NOTE: Specialty facilities for substance use treatment include hospitals (inpatient only), rehabilitation facilities (inpatient or outpatient), or mental health centers. Substance use treatment questions are asked of respondents who used alcohol or illicit drugs in their lifetime. Respondents who used prescription drugs but who did not misuse prescription drugs in their lifetime may not receive these questions.
NOTE: Mental health services including virtual services for people aged 12 to 17 includes treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown mental health services including virtual services information who could not be classified on substance use treatment data were excluded.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
NOTE: Respondents with unknown impairment data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.
220720
Table 7.16B – Received Substance Use Treatment at a Specialty Facility and/or Mental Health Services (Specialty or Nonspecialty) Including Virtual Services in Past Year: Among People Aged 12 to 17; by Past Year Illicit Drug or Alcohol Use Disorder and Major Depressive Episode (MDE) and MDE with Severe Impairment Status and Age Group, Percentages, 2021
Illicit Drug or Alcohol Use Disorder
Status/MDE Status/Age Group		 Received Substance Use
Treatment (SU Tx) at
a Specialty Facility OR
Mental Health (MH)
Services Including
Virtual Services (VS)
(2021)		 Received
SU Tx at a
Specialty
Facility BUT NOT MH
Services Including VS
(2021)		 Received
MH Services Including VS
BUT NOT
SU Tx at a Specialty
Facility
(2021)		 Received
SU Tx at
a Specialty Facility AND
MH Services Including VS
(2021)		 Received NEITHER SU
Tx at a Specialty Facility
NOR MH Services
Including VS
(2021)
Illicit Drug or Alcohol Use Disorder and MDE 56.1 * 52.4 3.6 43.9
12-13 * * * * *
14-15 * * * 3.7 *
16-17 49.3 * 45.0 * 50.7
Illicit Drug or Alcohol Use Disorder and
   MDE with Severe Impairment		 57.0 * 52.3 4.7 43.0
12-13 * * * * *
14-15 * * * 4.2 *
16-17 * * * * *
Illicit Drug or Alcohol Use Disorder and
   No MDE		 32.1 0.7 30.8 0.4 67.9
12-13 * * * * *
14-15 * * * 0.1 *
16-17 32.1 0.7 30.8 0.7 67.9
MDE and No Illicit Drug or Alcohol Use
   Disorder		 51.0 * 51.0 * 49.0
12-13 47.2 * 47.2 * 52.8
14-15 49.7 * 49.7 * 50.3
16-17 54.2 * 54.2 0.0 45.8
No Illicit Drug or Alcohol Use Disorder and
   No MDE		 18.6 0.0 18.6 * 81.4
12-13 20.2 0.0 20.2 * 79.8
14-15 18.7 0.1 18.6 0.0 81.3
16-17 16.6 * 16.6 * 83.4
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Illicit drug or alcohol use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table do not include prescription drug use disorder data from the past year users of prescription drugs who were not also misusers of prescription drugs. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details on these changes.
NOTE: Specialty facilities for substance use treatment include hospitals (inpatient only), rehabilitation facilities (inpatient or outpatient), or mental health centers. Substance use treatment questions are asked of respondents who used alcohol or illicit drugs in their lifetime. Respondents who used prescription drugs but who did not misuse prescription drugs in their lifetime may not receive these questions.
NOTE: Mental health services including virtual services for people aged 12 to 17 includes treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown mental health services including virtual services information who could not be classified on substance use treatment data were excluded.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
NOTE: Respondents with unknown impairment data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.
220720
Table 7.17A – Received Substance Use Treatment at a Specialty Facility and/or Mental Health Services (Specialty or Nonspecialty) in Past Year: Among People Aged 12 to 17; by Past Year Illicit Drug or Alcohol Use Disorder and Major Depressive Episode (MDE) and MDE with Severe Impairment Status and Age Group, Numbers in Thousands, 2021
Illicit Drug or Alcohol Use Disorder
Status/MDE Status/Age Group		 Received Substance Use
Treatment (SU Tx) at
a Specialty Facility OR
Mental Health (MH)
Services
(2021)		 Received
SU Tx at a
Specialty
Facility BUT NOT MH
Services
(2021)		 Received
MH Services BUT NOT
SU Tx at a Specialty
Facility
(2021)		 Received
SU Tx at
a Specialty Facility AND
MH Services
(2021)		 Received NEITHER SU
Tx at a Specialty Facility
NOR MH Services
(2021)
Illicit Drug or Alcohol Use Disorder and MDE 463 * 432 31 376
12-13 * * * * *
14-15 * * * 9 *
16-17 232 * 211 * 255
Illicit Drug or Alcohol Use Disorder and
   MDE with Severe Impairment		 366 * 335 31 282
12-13 * * * * *
14-15 * * * 9 *
16-17 * * * * *
Illicit Drug or Alcohol Use Disorder and
   No MDE		 312 8 298 4 702
12-13 * * * * *
14-15 * * * 0 *
16-17 189 5 180 3 424
MDE and No Illicit Drug or Alcohol Use
   Disorder		 2,000 * 2,000 * 2,128
12-13 449 * 449 * 522
14-15 669 * 669 * 763
16-17 882 * 882 0 844
No Illicit Drug or Alcohol Use Disorder and
   No MDE		 3,331 7 3,324 * 15,284
12-13 1,382 1 1,382 * 5,733
14-15 1,077 6 1,071 0 4,988
16-17 871 * 871 * 4,564
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Illicit drug or alcohol use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table do not include prescription drug use disorder data from the past year users of prescription drugs who were not also misusers of prescription drugs. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details on these changes.
NOTE: Specialty facilities for substance use treatment include hospitals (inpatient only), rehabilitation facilities (inpatient or outpatient), or mental health centers. Substance use treatment questions are asked of respondents who used alcohol or illicit drugs in their lifetime. Respondents who used prescription drugs but who did not misuse prescription drugs in their lifetime may not receive these questions.
NOTE: Mental health services including virtual services for people aged 12 to 17 includes treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown mental health services including virtual services information who could not be classified on substance use treatment data were excluded.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
NOTE: Respondents with unknown impairment data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.
220720
Table 7.17B – Received Substance Use Treatment at a Specialty Facility and/or Mental Health Services (Specialty or Nonspecialty) in Past Year: Among People Aged 12 to 17; by Past Year Illicit Drug or Alcohol Use Disorder and Major Depressive Episode (MDE) and MDE with Severe Impairment Status and Age Group, Percentages, 2021
Illicit Drug or Alcohol Use Disorder
Status/MDE Status/Age Group		 Received Substance Use
Treatment (SU Tx) at
a Specialty Facility OR
Mental Health (MH)
Services
(2021)		 Received
SU Tx at a
Specialty
Facility BUT NOT MH
Services
(2021)		 Received
MH Services BUT NOT
SU Tx at a Specialty
Facility
(2021)		 Received
SU Tx at
a Specialty Facility AND
MH Services
(2021)		 Received NEITHER SU
Tx at a Specialty Facility
NOR MH Services
(2021)
Illicit Drug or Alcohol Use Disorder and MDE 55.2 * 51.5 3.6 44.8
12-13 * * * * *
14-15 * * * 3.7 *
16-17 47.6 * 43.3 * 52.4
Illicit Drug or Alcohol Use Disorder and
   MDE with Severe Impairment		 56.5 * 51.7 4.7 43.5
12-13 * * * * *
14-15 * * * 4.2 *
16-17 * * * * *
Illicit Drug or Alcohol Use Disorder and
   No MDE		 30.8 0.8 29.4 0.4 69.2
12-13 * * * * *
14-15 * * * 0.1 *
16-17 30.8 0.8 29.4 0.5 69.2
MDE and No Illicit Drug or Alcohol Use
   Disorder		 48.4 * 48.4 * 51.6
12-13 46.2 * 46.2 * 53.8
14-15 46.7 * 46.7 * 53.3
16-17 51.1 * 51.1 0.0 48.9
No Illicit Drug or Alcohol Use Disorder and
   No MDE		 17.9 0.0 17.9 * 82.1
12-13 19.4 0.0 19.4 * 80.6
14-15 17.8 0.1 17.7 0.0 82.2
16-17 16.0 * 16.0 * 84.0
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Illicit drug or alcohol use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table do not include prescription drug use disorder data from the past year users of prescription drugs who were not also misusers of prescription drugs. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details on these changes.
NOTE: Specialty facilities for substance use treatment include hospitals (inpatient only), rehabilitation facilities (inpatient or outpatient), or mental health centers. Substance use treatment questions are asked of respondents who used alcohol or illicit drugs in their lifetime. Respondents who used prescription drugs but who did not misuse prescription drugs in their lifetime may not receive these questions.
NOTE: Mental health services including virtual services for people aged 12 to 17 includes treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown mental health services including virtual services information who could not be classified on substance use treatment data were excluded.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
NOTE: Respondents with unknown impairment data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.
220720
Table 7.18A – Had Serious Thoughts of Suicide, Made Any Suicide Plans, and Attempted Suicide in Past Year: Among People Aged 12 to 17; by Demographic Characteristics, Numbers in Thousands, 2021
Suicidal Thoughts/Behavior Aged 12-17
(2021)		 Aged 12-13
(2021)		 Aged 14-15
(2021)		 Aged 16-17
(2021)		 Male
(2021)		 Female
(2021)
HAD SERIOUS THOUGHTS OF SUICIDE            
Yes 3,295 890 1,113 1,292 1,067 2,229
No 18,241 6,436 5,909 5,896 10,560 7,682
Not Sure/Don’t Know 2,047 663 689 695 859 1,188
Don’t Want to Answer/Refuse 2,333 981 709 643 738 1,595
MADE ANY SUICIDE PLANS            
Yes 1,518 462 510 545 423 1,094
No 21,551 7,473 6,986 7,092 11,820 9,731
Not Sure/Don’t Know 941 273 336 331 339 601
Don’t Want to Answer/Refuse 1,907 763 588 557 641 1,267
ATTEMPTED SUICIDE            
Yes 892 299 301 292 279 613
No 22,981 7,844 7,476 7,661 12,266 10,715
Not Sure/Don’t Know 492 203 152 137 140 352
Don’t Want to Answer/Refuse 1,552 625 491 436 539 1,013
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Respondents with unknown suicide data other than the categories shown in this table were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.
220720
Table 7.18B – Had Serious Thoughts of Suicide, Made Any Suicide Plans, and Attempted Suicide in Past Year: Among People Aged 12 to 17; by Demographic Characteristics, Percentages, 2021
Suicidal Thoughts/Behavior Aged 12-17
(2021)		 Aged 12-13
(2021)		 Aged 14-15
(2021)		 Aged 16-17
(2021)		 Male
(2021)		 Female
(2021)
HAD SERIOUS THOUGHTS OF SUICIDE            
Yes 12.7 9.9 13.2 15.2 8.1 17.6
No 70.4 71.7 70.2 69.2 79.9 60.5
Not Sure/Don’t Know 7.9 7.4 8.2 8.1 6.5 9.4
Don’t Want to Answer/Refuse 9.0 10.9 8.4 7.5 5.6 12.6
MADE ANY SUICIDE PLANS            
Yes 5.9 5.2 6.1 6.4 3.2 8.6
No 83.2 83.3 83.0 83.2 89.4 76.7
Not Sure/Don’t Know 3.6 3.0 4.0 3.9 2.6 4.7
Don’t Want to Answer/Refuse 7.4 8.5 7.0 6.5 4.8 10.0
ATTEMPTED SUICIDE            
Yes 3.4 3.3 3.6 3.4 2.1 4.8
No 88.7 87.4 88.8 89.9 92.8 84.4
Not Sure/Don’t Know 1.9 2.3 1.8 1.6 1.1 2.8
Don’t Want to Answer/Refuse 6.0 7.0 5.8 5.1 4.1 8.0
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Respondents with unknown suicide data other than the categories shown in this table were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.
220720
Table 7.19A – Attempted Suicide in Past Year: Among People Aged 12 to 17; Received Medical Attention for Suicide Attempt in Past Year and Stayed Overnight or Longer in a Hospital for Suicide Attempt in Past Year: Among People Aged 12 to 17 Who Attempted Suicide in Past Year; by Demographic Characteristics, Numbers in Thousands, 2021
Suicidal Behavior/Treatment for Suicide Attempt Aged 12-17
(2021)		 Aged 12-13
(2021)		 Aged 14-15
(2021)		 Aged 16-17
(2021)		 Male
(2021)		 Female
(2021)
ATTEMPTED SUICIDE            
Yes 892 299 301 292 279 613
No 22,981 7,844 7,476 7,661 12,266 10,715
Not Sure/Don’t Know 492 203 152 137 140 352
Don’t Want to Answer/Refuse 1,552 625 491 436 539 1,013
RECEIVED MEDICAL ATTENTION FOR SUICIDE
ATTEMPT AMONG PEOPLE WHO ATTEMPTED
SUICIDE		            
Yes 291 * 104 * * 178
No 537 * 182 * * 388
Not Sure/Don’t Know 34 * 7 2 6 27
Don’t Want to Answer/Refuse 31 14 8 * * 20
STAYED OVERNIGHT OR LONGER IN A
HOSPITAL FOR SUICIDE ATTEMPT AMONG
PEOPLE WHO ATTEMPTED SUICIDE		            
Yes 163 * 57 * * 97
No 652 * * * * 466
Not Sure/Don’t Know 3 * * * * *
Don’t Want to Answer/Refuse * * * 1 * 0
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Respondents with unknown suicide data other than the categories shown in this table were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.
220720
Table 7.19B – Attempted Suicide in Past Year: Among People Aged 12 to 17; Received Medical Attention for Suicide Attempt in Past Year and Stayed Overnight or Longer in a Hospital for Suicide Attempt in Past Year: Among People Aged 12 to 17 Who Attempted Suicide in Past Year; by Demographic Characteristics, Percentages, 2021
Suicidal Behavior/Treatment for Suicide Attempt Aged 12-17
(2021)		 Aged 12-13
(2021)		 Aged 14-15
(2021)		 Aged 16-17
(2021)		 Male
(2021)		 Female
(2021)
ATTEMPTED SUICIDE            
Yes 3.4 3.3 3.6 3.4 2.1 4.8
No 88.7 87.4 88.8 89.9 92.8 84.4
Not Sure/Don’t Know 1.9 2.3 1.8 1.6 1.1 2.8
Don’t Want to Answer/Refuse 6.0 7.0 5.8 5.1 4.1 8.0
RECEIVED MEDICAL ATTENTION FOR SUICIDE
ATTEMPT AMONG PEOPLE WHO ATTEMPTED
SUICIDE		            
Yes 32.6 * 34.4 * * 29.0
No 60.2 * 60.5 * * 63.4
Not Sure/Don’t Know 3.8 * 2.3 0.8 2.3 4.4
Don’t Want to Answer/Refuse 3.4 4.7 2.8 * * 3.2
STAYED OVERNIGHT OR LONGER IN A
HOSPITAL FOR SUICIDE ATTEMPT AMONG
PEOPLE WHO ATTEMPTED SUICIDE		            
Yes 19.7 * 19.8 * * 17.2
No 78.8 * * * * 82.3
Not Sure/Don’t Know 0.3 * * * * *
Don’t Want to Answer/Refuse * * * 0.2 * 0.0
* = low precision; -- = not available; da = does not apply; nr = not reported due to measurement issues.
NOTE: Estimates from years prior to 2021 are not shown because of methodological changes in 2021. See the 2021 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Respondents with unknown suicide data other than the categories shown in this table were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021.

Go to Top of PageGo to the Table of Contents